Gabapentin

February 24, 2025
Seniors take me for all sorts of medical issues.
What molecule am I?
Image of Gabapentin 3D Image of Gabapentin

Gabapentin is a nonprotein amino acid and a synthetic neurotransmitter that is related to γ-aminobutyric acid1 (GABA). It was first described in 1976 West German patent DE2460891 on cyclic amino acids to Gerhard Satzinger and co-inventors at Goedecke AG (Freiburg). The corresponding US Patent is 4,024,175 (1977).

Gabapentin crosses the blood–brain barrier more easily than GABA. In the early patents, the Goedecke researchers noted that the compound is a sedative; and in mice, it prevented seizures triggered by a GABA antagonist. Preliminary clinical trials in the 1980s indicated that gabapentin appeared to be effective against spasticity and migraines.

Under the trade name Neurontin, gabapentin was approved in 1993 in the United Kingdom for treating refractive epilepsy and by the US Food and Drug Administration as an adjuvant medication for partial seizures. Since then, its uses have steadily increased to treat conditions such as neuropathic pain, anxiety, sleep disorders, and drug dependence.

In a 2024 article in The New York Times, writer Paula Span quoted Michael Steinman, a geriatrician at the University of California, San Francisco, as saying this about gabapentin: —especially among seniors. The interviewed patients were taking the drug off-label to treat the pain and fatigue of fibromyalgia, foot and leg pain from transverse myelitis, rheumatoid arthritis, agitation from dementia, and a host of other disorders.

1. CAS Reg. No. 56-12-2.

Gabapentin hazard information*

Hazard class**GHS code and hazard statement
Skin corrosion/irritation, category 2H315—Causes skin irritationChemical Safety Warning
Serious eye damage/eye irritation,
category 2A
H319—Causes serious eye irritationChemical Safety Warning
Specific target organ toxicity, single
exposure, respiratory tract irritation, category 3
H335—May cause respiratory irritationChemical Safety Warning
Specific target organ toxicity, single
exposure, narcotic effects, category 3
H336—May cause drowsiness or dizzinessChemical Safety Warning
Reproductive toxicity, category 1BH360—May damage fertility or the unborn childChemical Safety Warning
Short-term (acute) aquatic hazard, category 1H400—Very toxic to aquatic lifeChemical Safety Warning
Long-term (chronic) aquatic hazard, category 1H410—Very toxic to aquatic life with long-lasting effectsChemical Safety Warning

*Compilation of multiple safety data sheets.
**Globally Harmonized System (GHS) of Classification and Labeling of Chemicals. .

Molecules from the Journals

Europium(II) chloride1 (EuCl2) is a salt of the lanthanide (“rare earth�) element europium. In 1935, Karl Przibram at the Institute for Radium Research (Vienna) showed that blue fluorescence from the mineral fluorite2 (CaF2) is caused by . The compound is synthesized via the reduction of europium(III) chloride3 with hydrogen or lithium borohydride.

This past December, Fengxia Hu, Jing Wang, Baogen Shen, and collaborators at multiple Chinese institutions reported that the orthorhombic crystalline form of EuCl2 could be the key to a . The researchers found that the exceptionally large magnetocaloric effect of EuCl2 drives a process called adiabatic demagnetization refrigeration, which can achieve sub-kelvin cryogenic temperatures as low as �346 mK.

Indium phosphide4 (InP) is a binary crystalline compound and a semiconductor. It was first described in 1910 by Alfred Thiel* and H. Koelsch at the University of Münster (Germany) in a treatise called “�. The chemists prepared InP by heating indium(I) iodide5 in the presence of phosphorus vapor.

InP nanocrystals (NCs) are in high demand because their luminosity is useful in displays and bioimaging. In January, Fei Huang, Jianjun Tian, and co-workers at the University of Science and Technology Beijing reported a . They decomposed ammonium hypophosphite6 [(NH4)H2PO2] to generate gaseous phosphine7 (PH3), which reacts with an indium carboxylate8 to form InP clusters. They then used the clusters to grow high-quality NCs with uniform size distribution.

1. CAS Reg. No. 13769-20-5.
2. CAS Reg. No. 14542-23-5.
3. CAS Reg. No. 10025-76-0.
4. CAS Reg. No. 22398-80-7.
5. CAS Reg. No. 13966-94-4.
6. CAS Reg. No. 7803-65-8.
7. CAS Reg. No. 7803-51-2.
8. e.g., indium oleate.

Molecules from the Journals

MOTW briefly describes noteworthy molecules that appeared in recent ACS journal articles. See this week's edition.

This molecule was suggested by a reader. We present almost all of the molecules suggested by our readers. If you have a molecule you would like us to consider, please send us a message. And thank you for your interest in Molecule of the Week! —Ed.


Gabapentin fast facts

CAS Reg. No.60142-96-3
SciFindern nameCyclohexaneacetic
acid, 1-(aminomethyl)-
Empirical
formula
C9H17NO2
Molar mass171.24Ìý²µ/³¾´Ç±ô
AppearanceWhite to off-white
crystalline solid
Melting point165�167 ºC
Water
solubility
4.5 g/L (25 ºC)
Chemical Abstract Service - a division of ACS

, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.